Vertex Pharmaceuticals (VRTX) Free Cash Flow (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted Free Cash Flow of $1.0 billion for Q2 2026, down 21.74% on a QoQ basis from $1.3 billion in Q1 2026, and up 9.25% year-over-year from $927.4 million in Q2 2025.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Free Cash Flow (2009 - 2026) Analysis & Trends
Vertex Pharmaceuticals has reported Free Cash Flow for 18 years, with the latest figure at $1.0 billion in Q2 2026.
- On a quarterly basis, Free Cash Flow rose 9.25% year-over-year to $1.0 billion in Q2 2026; TTM through Jun 2026 was $3.8 billion, a 8.47% increase from a year earlier, with the FY2025 full-year figure at $3.2 billion, up 504.13% from the prior year.
- Free Cash Flow was $1.0 billion for Q2 2026 at Vertex Pharmaceuticals, down from $1.3 billion in the prior quarter.
- The five-year high for Free Cash Flow was $1.3 billion in Q3 2024, with the low at -$3.8 billion in Q2 2024.
- Average Free Cash Flow over 5 years is $665.2 million, with a median of $970.3 million recorded in 2025.
- The sharpest annual moves came in 2022 and 2024: Free Cash Flow surged 535.3% in 2022, then tumbled 455.66% in 2024.
- Over 5 years, Free Cash Flow stood at $1.0 billion in 2022, then plunged by 83.11% to $176.5 million in 2023, then soared by 178.75% to $492.0 million in 2024, then retreated by 29.15% to $348.6 million in 2025, then soared by 190.65% to $1.0 billion in 2026.
- The last three Free Cash Flow figures came in at $1.0 billion (Q2 2026), $1.3 billion (Q1 2026), and $348.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 7.30 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 3.11 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 4.48 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 6.20 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 3.63 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 3.49 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 3.43 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 302.00 Mn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 1.01 Bn |
| 10 | Bristol Myers Squibb | 124.95 Bn | 113.89 Bn | 9.25 Bn | 3.09 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.01 Bn |
| Mar 31, 2026 | 1.29 Bn |
| Dec 31, 2025 | 348.60 Mn |
| Sep 30, 2025 | 1.14 Bn |
| Jun 30, 2025 | 927.40 Mn |
| Mar 31, 2025 | 778.20 Mn |
| Dec 31, 2024 | 492.00 Mn |
| Sep 30, 2024 | 1.30 Bn |
| Jun 30, 2024 | -3.82 Bn |
| Mar 31, 2024 | 1.24 Bn |
| Dec 31, 2023 | 176.50 Mn |
| Sep 30, 2023 | 1.23 Bn |
| Jun 30, 2023 | 1.07 Bn |
| Mar 31, 2023 | 857.80 Mn |
| Dec 31, 2022 | 1.04 Bn |
| Sep 30, 2022 | 901.30 Mn |
| Jun 30, 2022 | 1.09 Bn |
| Mar 31, 2022 | 892.60 Mn |
| Dec 31, 2021 | 933.20 Mn |
| Sep 30, 2021 | 874.80 Mn |
API Access
Vertex Pharmaceuticals Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();